Morning Digest | Covishield, Covaxin made fewer antibodies against B.1.617 variant; WHO chief says India’s COVID situation hugely concerning, and more
The Hindu
A select list of stories to read before you start your day.
Both Covishield and Covaxin, while effective at generating an immune response against the coronavirus, appear to generate only half as many antibodies against the B.1.617 strain, or the Indian strain, according to a series of early reports authored by scientists at the Indian Council of Medical Research (ICMR).More Related News
Everyone talks about the Airport Metro, but one look at the pillars and completion seems nowhere in sight. Meanwhile, a faster, cheaper, roomier alternative called the Suburban Rail Airport Corridor is finally getting off the drawing board. This dedicated corridor with its specialised coaches will link the airport to vast stretches of Bengaluru, where the metro connection is still years away.